Vanda Pharmaceuticals | Beneficio Operativo



Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 19.29M 134.21M 2025-03
Agios Pharmaceuticals USD -106629000 18.41M 2025-03
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
Arrowhead Research USD 381.2M 542.61M 2025-03
AstraZeneca USD 3.67B 1.64B 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Halozyme Therapeutics USD 141.54M 33.97M 2025-03
Insmed USD -248140000 17.73M 2025-03
J&J USD 13.63B 9.74B 2025-03
Ligand Pharmaceuticals USD -36216000 26.58M 2025-03
Merck USD 5.87B 1.57B 2025-03
Moderna USD -1050000000 196M 2025-03
Novartis USD 3.4B 193M 2024-12
Pfizer USD 3.67B 4.08B 2025-03
PTC Therapeutics USD 970.22M 1.03B 2025-03
Sanofi EUR 2.28B 1.42B 2025-03
Takeda JPY -74932000000 141.87B 2025-03
Teva Pharmaceutical Industries USD 519M 64M 2025-03
Ultragenyx Pharmaceutical USD -142939000 20.66M 2025-03
Veracyte USD 1.16M 3.01M 2025-03



Vanda Pharmaceuticals Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jul 2025.